NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/14/2024
Back to search
Official data from USPTO
INSTARELIEF
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
05/14/2024
Trademark type
Word
Nice classes
5
Filing date
11/17/2020
Registration date
05/14/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/14/2024
Last transaction
05/14/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/02/2023
First use in commerce
12/02/2023
Drawing code
4
Owner type
03
Owner location
Katy, TX, US
Examiner
MCNAMARA, SHANA
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
DXM Pharmaceutical, Inc.
Representatives
KEITH B. WILLHELM KEITH B. WILLHELM ATTORNEY AT LAW PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
over-the-counter antihistamine syrups for relieving allergy symptoms
Publications
History of USPTO decisions and trademark events.
45 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/14/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/12/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/11/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/23/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/22/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
02/22/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/15/2024
IUAF
USE AMENDMENT FILED
01/31/2024
EX2G
SOU EXTENSION 2 GRANTED
01/31/2024
EXT2
SOU EXTENSION 2 FILED
01/31/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
01/31/2024
EEXT
SOU TEAS EXTENSION RECEIVED
01/31/2024
EISU
TEAS STATEMENT OF USE RECEIVED
01/31/2024
DRRR
DIVISIONAL REQUEST RECEIVED
01/04/2024
DOCK
ASSIGNED TO EXAMINER
11/06/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/30/2023
EX1G
SOU EXTENSION 1 GRANTED
09/28/2023
EXT1
SOU EXTENSION 1 FILED
09/28/2023
EEXT
SOU TEAS EXTENSION RECEIVED
09/28/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/18/2023
TMBN
TTAB RELEASE CASE TO TRADEMARKS
03/08/2023
OP.T
OPPOSITION TERMINATED NO. 999999
03/08/2023
OP.D
OPPOSITION DISMISSED NO. 999999
03/08/2023
OP.I
OPPOSITION INSTITUTED NO. 999999
08/22/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
07/19/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/21/2022
PUBO
PUBLISHED FOR OPPOSITION
06/21/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/01/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/19/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/17/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/17/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/17/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/24/2021
GNFR
FINAL REFUSAL E-MAILED
11/24/2021
CNFR
FINAL REFUSAL WRITTEN
11/24/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/03/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/04/2021
GNRT
NON-FINAL ACTION E-MAILED
05/04/2021
CNRT
NON-FINAL ACTION WRITTEN
05/04/2021
DOCK
ASSIGNED TO EXAMINER
04/28/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/15/2021
NWAP
NEW APPLICATION ENTERED
11/20/2020
Continuous trademark protection
Get notified about every new filing that threatens INSTARELIEF or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.